A phase 2 efficacy and safety study of SU011248 [sunitinib] in patients with metastatic non-small cell lung cancer

Trial Profile

A phase 2 efficacy and safety study of SU011248 [sunitinib] in patients with metastatic non-small cell lung cancer

Completed
Phase of Trial: Phase II

Latest Information Update: 02 Jun 2011

At a glance

  • Drugs Sunitinib (Primary)
  • Indications Non-small cell lung cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 15 Oct 2008 Checked against ClinicalTrials.gov record - last updated 15 Oct 2008.
    • 14 Mar 2008 Status changed from in progress to completed on ClinicalTrials.gov
    • 03 Jan 2008 The expected completion date for this trial is now 1 Mar 2007.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top